Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

892 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.
Katsumata N, Yasuda M, Isonishi S, Takahashi F, Michimae H, Kimura E, Aoki D, Jobo T, Kodama S, Terauchi F, Sugiyama T, Ochiai K; Japanese Gynecologic Oncology Group. Katsumata N, et al. Among authors: ochiai k. Lancet Oncol. 2013 Sep;14(10):1020-6. doi: 10.1016/S1470-2045(13)70363-2. Epub 2013 Aug 13. Lancet Oncol. 2013. PMID: 23948349 Clinical Trial.
Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer.
Sugiyama T, Yakushiji M, Kamura T, Ikeda M, Umesaki N, Hasegawa K, Ishikawa M, Saji F, Hiura M, Takahashi T, Sato S, Ochiai K, Kikkawa F, Takeuchi S, Ohashi Y, Noda K; Japan CPT-11 Study Group. Sugiyama T, et al. Among authors: ochiai k. Oncology. 2002;63(1):16-22. doi: 10.1159/000065715. Oncology. 2002. PMID: 12187066 Clinical Trial.
Japanese ovarian trials: focus on irinotecan.
Sugiyama T, Yakushiji M, Ochiai K, Noda K. Sugiyama T, et al. Among authors: ochiai k. Oncology (Williston Park). 2003 May;17(5 Suppl 5):29-33. Oncology (Williston Park). 2003. PMID: 12800603 Review.
Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
Noda K, Ohashi Y, Sugimori H, Ozaki M, Niibe H, Ogita S, Kohno I, Hasegawa K, Kikuchi Y, Takegawa Y, Fujii S, Tanaka K, Ochiai K, Kita M, Fujiwara K. Noda K, et al. Among authors: ochiai k. Gynecol Oncol. 2006 Jun;101(3):455-63. doi: 10.1016/j.ygyno.2005.11.006. Epub 2005 Dec 19. Gynecol Oncol. 2006. PMID: 16360199 Clinical Trial.
892 results